Weck, A.J. Dal Canto, and S.H. Speck. 1997. Complete se- quence and genomic analysis of murine gammaherpesvirus 68. J. Virol. 71:5894–5904. 6. Wang, G.H., T.L. Garvey, and J.I. Cohen. 1999. The murine gammaherpesvirus-68 M11 protein inhibits Fas- and TNF- induced apoptosis. J. Gen. Virol. 80:2737–2740. 7. Bellows, D.S., B.N. Chau, P. Lee, Y. Lazebnik, W.H. Burns, and J.M. Hardwick. 2000. Antiapoptotic herpesvirus bcl-2 homologs escape caspase-mediated conversion to proapop- totic proteins. J. Virol. 74:5024–5031. 8. Henderson, S., D. Huen, M. Rowe, C. Dawson, G. Johnson, and A. Rickinson. 1993. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc. Natl. Acad. Sci. USA. 90: 8479–8483. 9. Sarid, R., T. Sato, R.A. Bohenzky, J.J. Russo, and Y. Chang. 1997. Kaposi’s sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nat. Med. 3:293–298. 10. Nava, V.E., E.H. Cheng, M. Veliuona, S. Zou, R.J. Clem, M.L. Mayer, and J.M. Hardwick. 1997. Herpesvirus saimiri en- codes a functional homolog of the human bcl-2 oncogene. J. Virol. 71:4118–4122. 11. Brun, A., F. Rodriguez, J.M. Escribano, and C. Alonso. 1998. Functionality and cell anchorage dependence of the African swine fever virus gene A179L, a viral bcl-2 homolog, in insect cells. J. Virol. 72:10227–10233. 12. Brun, A., C. Rivas, M. Esteban, J.M. Escribano, and C. Alonso. 1996. African swine fever virus gene A179L, a viral homologue of bcl-2, protects cells from programmed cell death. Virology. 225:227–230. 13. Sundararajan, R., and E. White. 2001. E1B 19K blocks Bax oligomerization and tumor necrosis factor alpha-mediated apoptosis. J. Virol. 75:7506–7516. 14. Perez, D., and E. White. 2000. TNF-alpha signals apoptosis through a bid-dependent conformational change in Bax that is inhibited by E1B 19K. Mol. Cell. 6:53–63. 15. Han, J., D. Modha, and E. White. 1998. Interaction of E1B 19K with Bax is required to block Bax-induced loss of mito- chondrial membrane potential and apoptosis. Oncogene. 17: 2993–3005. 16. Han, J., H.D. Wallen, G. Nunez, and E. White. 1998. E1B 19,000-molecular-weight protein interacts with and inhibits CED-4-dependent, FLICE-mediated apoptosis. Mol. Cell Biol. 18:6052–6062. 17. Marchini, A., B. Tomkinson, J.I. Cohen, and E. Kieff. 1991. BHRF1, the Epstein-Barr virus gene with homology to bcl2, is dispensable for B-lymphocyte transformation and virus rep- lication. J. Virol. 65:5991–6000. 18. Van Dyk, L.F., H.W. Virgin, and S.H. Speck. 2000. The murine gammaherpesvirus 68 v-cyclin is a critical regulator of reactivation from latency. J. Virol. 74:7451–7461. 19. Albrecht, J.-C., J. Nicholas, D. Biller, K.R. Cameron, B. Biesinger, C. Newman, S. Wittmann, M.A. Craxton, H. Coleman, B. Fleckenstein, and R.W. Honess. 1992. Primary structure of the herpesvirus saimiri genome. J. Virol. 66: 5047–5058. 20. Russo, J.J., R.A. Bohenzky, M.-C. Chien, J. Chen, M. Yan, D. Maddalena, J.P. Parry, D. Peruzzi, I.S. Edelman, Y. Chang, and P.S. Moore. 1996. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. USA. 93:14862–14867. 21. Jung, J.U., M. Stager, and R.C. Desrosiers. 1994. Virus- encoded cyclin. Mol. Cell. Biol. 14:7235–7244. 939 Gangappa et al. 22. Nicholas, J., K.R. Cameron, and R.W. Honess. 1992. Her- pesvirus saimiri encodes homologs of G protein-coupled re- ceptors and cyclins. Nature. 355:362–365. 23. Arvanitakis, L., N. Yaseen, and S. Sharma. 1995. Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta-1-mediated growth inhibition on EBV-positive B cells. J. Immunol. 155: 1047–1056. 24. Cannell, E.J., P.J. Farrell, and A.J. Sinclair. 1996. Epstein- Barr virus exploits the normal cell pathway to regulate Rb activity during the immortalisation of primary B-cells. Onco- gene. 13:1413–1421. 25. Sinclair, A.J., I. Palmero, A. Holder, G. Peters, and P.J. Far- rell. 1995. Expression of cyclin D2 in Epstein-Barr virus pos- itive Burkitt’s lymphoma cell lines is related to methylation status of the gene. J. Virol. 69:1292–1295. 26. Van Dyk, L.F., J.L. Hess, J.D. Katz, M. Jacoby, S.H. Speck, and H.W. Virgin. 1999. The murine gammaherpesvirus 68 v-cyclin is an oncogene that promotes cell cycle progression in primary lymphocytes. J. Virol. 73:5110–5122. 27. Hoge, A.T., S.B. Hendrickson, and W.H. Burns. 2000. Mu- rine gammaherpesvirus 68 cyclin D homologue is required for efficient reactivation from latency. J. Virol. 74:7016– 7023. 28. Weck, K.E., M.L. Barkon, L.I. Yoo, S.H. Speck, and H.W. Virgin. 1996. Mature B cells are required for acute splenic in- fection, but not for establishment of latency, by murine gam- maherpesvirus 68. J. Virol. 70:6775–6780. 29. Clambey, E.T., H.W. Virgin, and S.H. Speck. 2000. Disrup- tion of the murine gammaherpesvirus 68 M1 open reading frame leads to enhanced reactivation from latency. J. Virol. 74:1973–1984. 30. Muller, U., S. Steinhoff, L.F.L. Reis, S. Hemmi, J. Pavlovic, R.M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science. 264: 1918–1921. 31. Weck, K.E., S.S. Kim, H.W. Virgin, and S.H. Speck. 1999. Macrophages are the major reservoir of latent murine gam- maherpesvirus 68 in peritoneal cells. J. Virol. 73:3273–3283. 32. Weck, K.E., A.J. Dal Canto, J.D. Gould, A.K. O’Guin, K.A. Roth, J.E. Saffitz, S.H. Speck, and H.W. Virgin. 1997. Mu- rine gammaherpesvirus 68 causes large vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus induced vascular disease. Nat. Med. 3:1346–1353. 33. Dal Canto, A.J., H.W. Virgin, and S.H. Speck. 2000. Ongo- ing viral replication is required for gammaherpesvirus 68- induced vascular damage. J. Virol. 74:11304–11310. 34. Weck, K.E., S.S. Kim, H.W. Virgin, and S.H. Speck. 1999. B cells regulate murine gammaherpesvirus 68 latency. J. Vi- rol. 73:4651–4661. 35. Bodaghi, B., T.R. Jones, D. Zipeto, C. Vita, L. Sun, L. Lau- rent, F. Arenzana-Seisdedos, J.L. Virelizier, and S. Michel- son. 1998. Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J. Exp. Med. 188:855–866. 36. Penfold, M.E., D.J. Dairaghi, G.M. Duke, N. Saederup, E.S. Mocarski, G.W. Kemble, and T.J. Schall. 1999. Cytomega- lovirus encodes a potent alpha chemokine. Proc. Natl. Acad. Sci. USA. 96:9839–9844. 37. Patterson, C.E., and T. Shenk. 1999. Human cytomegalovi- rus UL36 protein is dispensable for viral replication in cul- tured cells. J. Virol. 73:7126–7131.